Quick Answer
Tempest Therapeutics, Inc. reported Total Assets of $16.93 million for the year ending 2025.
- Tempest Therapeutics, Inc. showed a decrease of -59.2% in Total Assets from 2024 to 2025.
- This data is from Tempest Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $34.99 million | Q3 2012: $36.33 million | Q2 2013: $56.24 million | Q3 2013: $51.23 million | Q1 2014: $92.76 million | Q2 2014: $85.83 million | Q3 2014: $77.50 million | Q1 2015: $175.78 million | Q2 2015: $164.45 million | Q3 2015: $152.81 million | Q1 2016: $122.06 million | Q2 2016: $158.72 million | Q3 2016: $142.40 million | Q1 2017: $106.32 million | Q2 2017: $93.89 million | Q3 2017: $82.03 million | Q1 2018: $63.03 million | Q2 2018: $55.53 million | Q3 2018: $49.23 million | Q1 2019: $74.31 million | Q2 2019: $68.32 million | Q3 2019: $58.48 million | Q1 2020: $68.05 million | Q2 2020: $57.13 million | Q3 2020: $22.86 million | Q1 2021: $73.24 million | Q2 2021: $75.50 million | Q3 2021: $67.14 million | Q1 2022: $66.95 million | Q2 2022: $71.35 million | Q3 2022: $63.17 million | Q1 2023: $37.33 million | Q2 2023: $30.74 million | Q3 2023: $23.99 million | Q1 2024: $44.38 million | Q2 2024: $42.17 million | Q3 2024: $33.84 million | Q1 2025: $32.16 million | Q2 2025: $24.48 million | Q3 2025: $17.13 million.
- Over the full 15 years of available data (2011 to 2025), Tempest Therapeutics, Inc.'s Total Assets has grown by 269.3%.
- Historical annual values: Fiscal year 2025: $16.93 million | Fiscal year 2024: $41.49 million | Fiscal year 2023: $51.60 million | Fiscal year 2022: $46.09 million | Fiscal year 2021: $73.24 million | Fiscal year 2020: $22.86 million | Fiscal year 2019: $74.97 million | Fiscal year 2018: $84.07 million | Fiscal year 2017: $19.81 million | Fiscal year 2016: $122.54 million | Fiscal year 2015: $138.61 million | Fiscal year 2014: $65.57 million | Fiscal year 2013: $47.55 million | Fiscal year 2012: $32.81 million | Fiscal year 2011: $4.59 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: